Advertisement

Change in Bilirubin Level Following Acute Myocardial Infarction Is an Index for Heme Oxygenase Activation.

02:43 EDT 20th June 2013 | BioPortfolio

Summary of "Change in Bilirubin Level Following Acute Myocardial Infarction Is an Index for Heme Oxygenase Activation."


OBJECTIVES:
: Heme oxygenase 1 (HO-1) is rapidly induced by stress, degrading pro-oxidant heme into carbon monoxide, bilirubin, and free iron (Fe). Induction of HO-1 is an important defense mechanism against tissue injury. Here, we tested the hypothesis that HO-1 is activated in the myocardium after acute myocardial infarction (AMI) in humans.
METHODS:
: Changes in the HO-1 activity after AMI were analyzed by measuring serum levels of bilirubin and Fe. Blood samples were collected in patients with AMI (n = 41) serially after the interventional therapy and compared with non-AMI subjects (n = 18). HO-1 protein levels were measured in a sample of AMI patients (n = 12).
RESULTS:
: In AMI patients, but not in non-AMI subjects, serum levels of bilirubin (1.57 fold, P < 0.001) and Fe (1.35 fold, P < 0.01) were transiently elevated, both levels peaking 18-21 hours after the start of sampling. The peak changes in the levels of bilirubin and Fe in AMI patients were significantly correlated with each other. Furthermore, the serum HO-1 protein level was elevated, and its change was significantly correlated with the change in bilirubin level (r = 0.82, P < 0.005). Those with a high bilirubin response (peak levels >0.5 mg/dL) had richer collateral flow into the ischemic myocardium.
CONCLUSIONS:
: These results suggest that heme oxygenase (HO) was activated following AMI, and it was detectable in the serum. Our data provide the first evidence of HO-1 induction following stress in humans. The change in bilirubin level may be a novel index for high collateral flow formation following AMI.

Affiliation

From the Departments of Cardiovascular Physiology and Medicine, Cardiovascular Medicine, Clinical Laboratory Medicine, Hiroshima University Graduate School of Biomedical Sciences; and Department of Cardiology, Hiroshima City Hospital, Hiroshima, Japan.

Journal Details

This article was published in the following journal.

Name: Southern medical journal
ISSN: 1541-8243
Pages:

Links

Medical and Biotech [MESH] Definitions

Anterior Wall Myocardial Infarction

MYOCARDIAL INFARCTION in which the anterior wall of the heart is involved. Anterior wall myocardial infarction is often caused by occlusion of the left anterior descending coronary artery. It can be categorized as anteroseptal or anterolateral wall myocardial infarction.

Acute Coronary Syndrome

An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode but that does not usually result in MYOCARDIAL INFARCTION.

Inferior Wall Myocardial Infarction

MYOCARDIAL INFARCTION in which the inferior wall of the heart is involved. It is often caused by occlusion of the right coronary artery.

Hyperbilirubinemia, Hereditary

Inborn errors of bilirubin metabolism resulting in excessive amounts of bilirubin in the circulating blood, either because of increased bilirubin production or because of delayed clearance of bilirubin from the blood.

Nitric Oxide Donors

A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81)

PubMed Articles [ 23649 Associated PubMed Articles listed on BioPortfolio]

Changing axis deviation and acute myocardial infarction.

Changing axis deviation has been rarely reported also during atrial fibrillation or atrial flutter. Changing axis deviation has been also rarely reported during acute myocardial infarction associated...

Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case-control study.

BACKGROUND: Previous studies have shown an association between acute myocardial infarction and preceding respiratory infection. Contradictory evidence exists on the influence of influenza vaccination...

Short-term outcomes of acute myocardial infarction in patients with acute kidney injury: a report from the national cardiovascular data registry.

Acute kidney injury (AKI) is a risk factor for long-term adverse outcomes, including acute myocardial infarction and death. However, the relationship between severity of AKI and in-hospital outcomes i...

Letter by fresco regarding article "primary angioplasty versus fibrinolysis in acute myocardial infarction: long-term follow-up in the danish acute myocardial infarction 2 trial".

Impact of body mass index in the results after primary angioplasty in patients with ST segment elevation acute myocardial infarction.

Introduction: Obese patients submitted to elective coronary angioplasty have a paradoxical reduction in hospital and long-term mortality. In primary angioplasty setting, the relation with Body Mass In...

Clinical Trials [ 4831 Associated Clinical Trials listed on BioPortfolio]

Strain-Encoded Magnetic Resonance Imaging in Acute Myocardial Infarction

The aim of the study was therefore to evaluate whether myocardial deformation imaging performed by SENC allows for quantification of regional left ventricular function and is related to tr...

RElevance of Biomarkers for Future Risk of Thromboembolic Events in UnSelected Post-myocardial Infarction Patients

The study is an open, single center, observational study at the Cardiology Dept at Uppsala University Hospital. The number of patients included will be 410. The objectives are to: Evaluat...

Effect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion. The METOCARD-CNIC Trial.

The purpose of this study is to test whether early pre-reperfusion metoprolol administration in patients suffering and acute myocardial infarction might reduce the size of myocardial necro...

Sitagliptin Plus Granulocyte-colony Stimulating Factor in Acute Myocardial Infarction

Trial design: This Phase III, investigator-driven, randomised, placebo-controlled efficacy and safety study will compare the effects of Sitagliptin in combination with granulocyte-colony...

Primary Angioplasty for Acute Myocardial Infarction in Patients With Symptom Duration Above 12 Hours

Background: Acute balloon angioplasty is beneficial in patients with acute myocardial infarction. However, presently this treatment is not offered to patients with symptom duration above 1...

Search BioPortfolio:
Advertisement
Advertisement

Latest Biotech, Pharma and Healthcare News

No significant difference in the risk of Acute Coronary Syndrome (including Myocardial Infarction) seen with Pradaxa® (dabigatran etexilate) compared to enoxaparin for VTE prevention after orthopaedic surgery

STENTYS Clinical Study Demonstrating Superiority of Self-Apposing® Stents Over Conventional Stents Published in American College of Cardiology Journal

Sleep Apnea Can Reduce Severity Of Cardiac Injury During A Heart Attack, According To Montefiore Study

The AAPS Journal: External Validation of the Bilirubin–Atazanavir Nomogram for Assessment of Atazanavir Plasma Exposure in HIV-1-Infected Patients

New ESC Guidelines Recommend BRILINTA (Ticagrelor) in Acute Coronary Syndromes Patients with ST-Elevation

New Cardiac Electrical Biomarker Featured In Johns Hopkins Abstract Demonstrates Strong Correlation To High Sensitivity Troponin To Rule Out Acute Myocardial Ischemic Injury

Ventrix's VentriGel™ Demonstrates Potential to Prevent Heart Failure Following Heart Attack


Searches Linking to this Article